Login
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
30 January 2025 at 18:12
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
Normal view
Before yesterdayMain stream
Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report
6 January 2025 at 04:01
But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.
